Skip to content
  • Insights
    • All Insights
    • 2024 Year in Review
    • Pα+ Dashboard
  • Data
    • Psychedelic Company Financing Tracker
    • Psychedelic Drug Development Tracker
    • Worldwide Psychedelic Laws
    • U.S. Psychedelic Policy Reform
    • Psychedelic Patent Trackers
    • Psychedelic Stocks & Companies
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+ Content
  • Pα+ Sign in
Menu
  • Insights
    • All Insights
    • 2024 Year in Review
    • Pα+ Dashboard
  • Data
    • Psychedelic Company Financing Tracker
    • Psychedelic Drug Development Tracker
    • Worldwide Psychedelic Laws
    • U.S. Psychedelic Policy Reform
    • Psychedelic Patent Trackers
    • Psychedelic Stocks & Companies
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+ Content
  • Pα+ Sign in
Subscribe
Search
Close this search box.
Read more about the article Beckley Psytech Strengthens Pipeline and Development Team With Acquisition of Eleusis Therapeutics Limited

Beckley Psytech Strengthens Pipeline and Development Team With Acquisition of Eleusis Therapeutics Limited

  • Post published:October 24, 2022
  • Post category:Press Release
Read more about the article Psychedelic Science Leader Eleusis to Become Public Company in Merger with Silver Spike Acquisition Corp. II

Psychedelic Science Leader Eleusis to Become Public Company in Merger with Silver Spike Acquisition Corp. II

  • Post published:January 20, 2022
  • Post category:Press Release
Read more about the article Eleusis Accelerates Psychedelic Drug Discovery and Development Team with Appointment of David Nichols, Ph.D., as Director of Molecular Pharmacology

Eleusis Accelerates Psychedelic Drug Discovery and Development Team with Appointment of David Nichols, Ph.D., as Director of Molecular Pharmacology

  • Post published:January 11, 2021
  • Post category:Press Release
Read more about the article Eleusis Launches Clinical Development of Psychedelic Infusion Therapies for Major Depressive Disorder and Acquires Kalypso Wellness Centers

Eleusis Launches Clinical Development of Psychedelic Infusion Therapies for Major Depressive Disorder and Acquires Kalypso Wellness Centers

  • Post published:December 14, 2020
  • Post category:Press Release
Read more about the article LSU Health Foundation, New Orleans and Foundation Board of Directors Announce Strategic Investment to Support Prevention and Treatment of Inflammatory Eye Disease

LSU Health Foundation, New Orleans and Foundation Board of Directors Announce Strategic Investment to Support Prevention and Treatment of Inflammatory Eye Disease

  • Post published:September 6, 2020
  • Post category:Press Release
Read more about the article Interview with Shlomi Raz, CEO and Chairman of Eleusis

Interview with Shlomi Raz, CEO and Chairman of Eleusis

  • Post published:June 3, 2020
  • Post category:Interview

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

  • Insights
  • Jobs
  • Data
  • Subscribe to Pα+
  • Contact

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.

Subscribe to Pα+
  • Psychedelic Alpha © 2025, All Rights Reserved
  • Privacy Policy
  • Terms of Service

Subscribe to Our Free Newsletter

Join Pα+ for Premium Insights

Subscribe Annually ($200)
Subscribe Monthly ($20)
Learn More